Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Asan Medical Center · Samsung Medical Center · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
776
total citations
- FWCI
- 45.14
- Percentile
- 100%
- References
- 20
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Capecitabine
- Medicine
- Cisplatin
- Fluorouracil
- Internal medicine
- Oncology
- Cancer
- Chemotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.